Last reviewed · How we verify

lidocaine with propofol

Imam Abdulrahman Bin Faisal University · FDA-approved active Small molecule

Lidocaine and propofol together provide local anesthesia and intravenous sedation by blocking sodium channels and enhancing GABAergic inhibition, respectively.

Lidocaine and propofol together provide local anesthesia and intravenous sedation by blocking sodium channels and enhancing GABAergic inhibition, respectively. Used for Procedural sedation and analgesia, Local anesthesia during minor surgical procedures.

At a glance

Generic namelidocaine with propofol
SponsorImam Abdulrahman Bin Faisal University
Drug classLocal anesthetic and sedative-hypnotic combination
TargetVoltage-gated sodium channels (lidocaine); GABA-A receptors (propofol)
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Lidocaine is a local anesthetic that blocks voltage-gated sodium channels in nerve fibers, preventing action potential propagation and pain signal transmission. Propofol is a sedative-hypnotic agent that acts as a positive allosteric modulator of GABA-A receptors, enhancing inhibitory neurotransmission in the central nervous system. The combination is used to provide both local anesthesia and systemic sedation during procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: